Healthy Thai individuals aged 18 years and above immunogenicity, COVID-19. vaccine, booster
Conditions
Interventions
Booster with AZD1222 in individuals vaccinated with two-dose BBIBP-CorV at 3-6 months post second vaccination.,Booster with BNT162b2 in individuals vaccinated with two-dose BBIBP-CorV.,Booster with mR
Booster with AZD1222 in individuals vaccinated with two-dose BBIBP-CorV,Booster with BNT162b2 in individuals vaccinated with two-dose BBIBP-CorV,Booster with mRNA-1273 in individuals vaccinated with t
Sponsors
National Research Council of Thailand (NRCT)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Healthy Thai individuals above 18 years of age 2. Not previously infected with COVID-19 3. Provide informed consent
Exclusion criteria
Exclusion criteria: 1. Previously infected with COVID-19 2. Immunocompromised individuals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immunogenicity day 14 and 28 post booster anti- receptor-binding domain of SARS-CoV-2 | — |
Secondary
| Measure | Time frame |
|---|---|
| neutralizing activities against variants day 14 and 28 post booster sVNT,T cell response dat 14 and day 28 post boost Quantiferon SARS-CoV-2 | — |
Countries
Thailand
Contacts
Public ContactYong Poovorawan
Chulalongkorn University
Outcome results
None listed